# US 2017/0319746 A1 · A method for building a structure containing living cells

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0319746 A1
- Document ID: US20170319746A1
- Status: Published application
- Kind: A1
- Application number: 15/535,322
- Filed: 2014-12-12
- Published: 2017-11-09
- Earliest claimed: 2014-12-12
- Applicants: Ecole Polytechnique Federale De Lausanne (Epfl)
- Inventors: Matthias Lutolf; Andrea Negro
- Web page: https://patentgrep.com/patent/US20170319746A1

## CPC

- A61L 27/3804: {characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells}
- A61L 27/18: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- A61L 27/20: Polysaccharides
- A61L 27/26: Mixtures of macromolecular compounds
- A61L 27/38: {containing added animal cells (organs or tissue containing native cells A61L27/36)}
- A61L 27/48: with macromolecular fillers
- A61L 27/52: Hydrogels or hydrocolloids
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61L 27/58: Materials at least partially resorbable by the body
- A61L 27/60: Materials for use in artificial skin
- B29C 64/112: using individual droplets, e.g. from jetting heads
- B29C 64/40: Structures for supporting 3D objects during manufacture and intended to be sacrificed after completion thereof
- B33Y 10/00: Processes of additive manufacturing
- B33Y 70/00: Materials specially adapted for additive manufacturing
- B33Y 80/00: Products made by additive manufacturing
- C08J 3/075: Macromolecular gels
- C09D 11/102: containing macromolecular compounds obtained by reactions other than those only involving unsaturated carbon-to-carbon bonds
- C09D 11/14: based on carbohydrates
- C09D 105/04: Alginic acid; Derivatives thereof
- C09D 171/02: Polyalkylene oxides
- C12M 21/08: {for producing artificial tissue or for ex-vivo cultivation of tissue (prostheses A61F2/00, grafts A61L27/00)}
- C12M 23/16: {Microfluidic devices; Capillary tubes (integrated microfluidic structures B01L3/5027; microreactors B01J19/0093)}
- C12M 23/30: {biodegradable}
- C12M 25/14: {Scaffolds; Matrices (in general C12N5/0068)}
- C12M 29/10: {Perfusion}
- C12M 33/00: {Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus (chemical or physical laboratory apparatus in general B01L, devices for taking cell samples A61B10/0045, withdrawing or distributing predetermined quantities of fluid B01L99/00)}
- C12N 5/0062: {General methods for three-dimensional culture}
- C12N 5/0656: {Adult fibroblasts}
- C12N 9/1044: {Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII}
- C12P 19/04: Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
- C12Y 203/02013: Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
- C12Y 402/02003: Poly(beta-D-mannuronate) lyase (4.2.2.3)
- A61L 2300/414: Growth factors
- A61L 2400/18: Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment
- A61L 2430/00: Materials or treatment for tissue regeneration
- B29K 2071/02: {Polyalkylene oxides, e.g. PEO, i.e. polyethylene oxide, or derivatives thereof}
- B29K 2105/0061: {Gel or sol}
- B29K 2995/0056: Biocompatible, e.g. biopolymers or bioelastomers
- B32B 2556/00: Patches, e.g. medical patches, repair patches
- C08J 2305/04: Alginic acid; Derivatives thereof
- C08J 2371/02: Polyalkylene oxides
- C12N 2513/00: 3D culture
- C12N 2533/74: Alginate
- C12N 2537/10: Cross-linking
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- B29C: SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING (making preforms B29B11/00; making laminated products by combining previously unconnected layers which become one product whose layers will remain together B32B37/00 - B32B41/00)
- B33Y: ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- C08J: WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H (working, e.g. shaping, of plastics B29)
- C09D: COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR (cosmetics A61K; processes for applying liquids or other fluent materials to surfaces, in general, B05D; staining wood B27K5/02; glazes or vitreous enamels C03C; natural resins, French polish, drying-oils, driers, turpentine, per se, C09F; polishing compositions other than French polish, ski waxes C09G; adhesives or use of materials as adhesives C09J; materials for sealing or packing joints or covers C09K3/10; materials for stopping leaks C09K3/12; processes for the electrolytic or electrophoretic production of coatings C25D)
- C12M: APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; {APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12Y: ENZYMES
- B29K: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR {MOULDS, } REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B32B: LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM

## Abstract

A composition comprising a first material and a second material, wherein said first material is cross-linkable by a first cross-linking reaction and said second material is cross-linkable by a second cross-linking reaction, wherein said first cross-linking reaction and said second cross-linking reaction are inducible by a common activator.

## Claims

### Claim 1

A composition comprising a first material and a second material, wherein said first material is cross-linkable by a first cross-linking reaction and said second material is cross-linkable by a second cross-linking reaction, wherein said first cross-linking reaction and said second cross-linking reaction are inducible by a common activator.

### Claim 2 (depends on 1)

A composition as claimed in claim 1, wherein said first material is a polymer, preferably a biopolymer or wherein said first material is a polypeptide, a polysaccharide or a polynucleotide, wherein preferably said first material is a polysaccharide, preferably a polysaccharide derived from alginate.

### Claim at position 3

3-4. (canceled)

### Claim 5 (depends on 1)

A composition as claimed in claim 1, wherein said second material comprises a biocompatible synthetic or semi-synthetic polymer wherein preferably said second material comprises a hydrophilic polymer or a swellable polymer, and wherein preferably said second material comprises a copolymer of a hydrophilic polymer and an oligopeptide, wherein preferably said oligopeptide is or provides a substrate for said second cross-linking reaction, and wherein preferably said oligopeptide is or provides a substrate for at least one additional reaction, e.g. an enzymatic reaction.

### Claim at position 5

6-10. (canceled)

### Claim 11 (depends on 1)

A composition as claimed in claim 1, wherein said second material further comprises an additional biomolecule having a biological function, preferably a signalling molecule e.g. a cell-adhesive peptide or a growth factor.

### Claim 12 (depends on 1)

A composition as claimed in claim 1, wherein said second material comprises a modified or unmodified polyglycol, preferably wherein said second material comprises a modified or unmodified polyethylene glycol, e.q. a branched modified or unmodified polyethylene glycol.

### Claim 13

(canceled)

### Claim 14 (depends on 1)

A composition as claimed in claim 1, wherein said first material, when cross-linked by said first cross-linking reaction, is degradable by a first degradation reaction and said second material, when cross-linked by said second cross-linking reaction, is not degradable by said first degradation reaction.

### Claim 15 (depends on 1)

A composition as claimed in claim 1, wherein said common activator is a chemical or biological agent, wherein preferably said common activator is a chemical agent or wherein said common activator is an organic compound, a metal salt or ion, an acid or a base, wherein preferably said common activator is a metal ion, preferably an alkali metal ion or an alkaline earth metal ion, or wherein preferably said common activator is a calcium ion, preferably Ca+ or wherein said common activator is an enzyme cofactor.

### Claim at position 11

16-20. (canceled)

### Claim 21 (depends on 1)

A composition as claimed in claim 1, wherein said first cross-linking reaction and said second cross-linking reaction are different reactions, and wherein preferably said first cross-linking reaction and said second cross-linking reaction occur independently of each other, and wherein said first cross-linking reaction is relatively fast, preferably in the order of about 0.1 to 10 seconds, and said second cross-linking reaction is relatively slow, preferably in the order of about 10 to 60 minutes.

### Claim at position 13

22-23. (canceled)

### Claim 24 (depends on 1)

A composition as claimed in claim 1, further comprising a buffer, preferably tris (hydroxymethyl) aminomethane buffer and/or further comprising a chelating agent, preferably a biocompatible chelating agent, wherein preferably, said chelating agent comprises an organic acid, e.q. citric acid, or EDTA, preferably EDTA and/or further comprising a surfactant, preferably a nonionic propylene glycol- derived surfactant and/or further comprising an enzyme, preferably a cross-linking enzyme, wherein preferably said enzyme is a transglutaminase, preferably FXIIIa, wherein preferably said enzyme mediates said second cross-linking reaction.

### Claim at position 15

25-30. (canceled)

### Claim 31 (depends on 1)

A composition as claimed in claim 1, wherein said first cross-linking reaction and said second cross-linking reaction proceed under mutually compatible reaction conditions, wherein preferably said mutually compatible reaction conditions are physiological conditions.

### Claim 32

(canceled)

### Claim 33

A composition comprising a polysaccharide derived from alginate, a modified or unmodified polyethylene glycol and a transglutaminase.

### Claim 34 (depends on 1)

A composition as claimed in claim 1, comprising about 0.3 to 1.0% w/v of said first material, preferably about 0.5% w/v., preferably comprising about 2.0 to 3.5% w/v of said second material, preferably about 2.5% w/v.

### Claim 35

(canceled)

### Claim 36 (depends on 1)

A bioink comprising a composition as claimed in claim 1.

### Claim 37 (depends on 36)

A bioink as claimed in claim 36, further comprising cells, preferably eukaryotic cells, e.g. mammalian cells.

### Claim 38 (depends on 1, 36)

A hydrogel formed from the composition according to claim 1, or a bioink as claimed in claim 36.

### Claim 39

A hydrogel comprising a cross-linked first material formed by a first cross-linking reaction and a second cross-linked material formed by a second cross-linking reaction, wherein said first cross-linking reaction and said second cross-linking reaction are inducible by a common activator.

### Claim 40 (depends on 39)

A hydrogel as claimed in claim 39, wherein said cross-linked first material is a polypeptide, a polysaccharide or a polynucleotide, wherein preferably said cross-linked first material is a polysaccharide, preferably a polysaccharide derived from alginate.

### Claim 41

(canceled)

### Claim 42 (depends on 40)

A hydrogel as claimed in claim 40, wherein said cross-linked second material comprises a biocompatible synthetic or semisynthetic polymer, wherein preferably said second material comprises a co-polymer of a hydrophilic polymer and an oligopeptide, and wherein preferably said oligopeptide is or provides a substrate for said second cross-linking reaction and wherein preferably, said oligopeptide is or provides a substrate for at least one additional reaction, e.g. an enzymatic reaction.

### Claim at position 28

43-45. (canceled)

### Claim 46 (depends on 39)

A hydrogel as claimed in claim 39, wherein said second material further comprises an additional biomolecule having a biological function, preferably a signaling molecule e.g. a cell-adhesive peptide or a growth factor.

### Claim 47 (depends on 39)

A hydrogel as claimed in claim 39, wherein said cross-linked second material comprises a modified or unmodified polyethylene glycol, e.g. a branched modified or unmodified polyethylene glycol, and wherein preferably said cross-linked first material is selectively degradable in the presence of said cross-linked second material, wherein preferably said cross-linked first material is selectively degradable in a biocompatible process, preferably wherein said cross-linked first material is selectively degradable using an enzyme; and
wherein preferably said cross-linked second material is selectively degradable by a cell-controlled mechanism, and preferably said cross-linked second material is selectively degradable using an enzyme, preferably a cell-secreted protease, e.g. a matrix metalloprotease.

### Claim at position 31

48-52. (canceled)

### Claim 53 (depends on 1, 36)

A structure formed from a composition according to claim 1 or a bioink according to claim 36.

### Claim 54 (depends on 38)

A structure comprising a hydrogel according to claim 38, wherein preferably the structure comprises living cells, preferably living eukaryotic cells, e.g. living mammalian cells, wherein preferably said living cells are present in said first composition or said cross-linked first composition.

### Claim at position 34

55-56. (canceled)

### Claim 57 (depends on 1, 36, 53)

A method of making a structure according to claim 53, comprising depositing a composition according to claim 1 or a bioink according to claim 36 on a substrate, wherein said substrate provides a common activator for inducing said first cross-linking reaction in said first composition and said second cross-linking reaction in said second composition.

### Claim 58

A method of making a structure, comprising the steps of: i. forming at least one, preferably a plurality of, sacrificial layer(s) on a substrate; ii. forming at least one, preferably a plurality of, permanent layer (s) on said substrate or said first sacrificial layer (s); and
wherein said at least one sacrificial layer is derived from a first composition and said at least one permanent layer is derived from at least one second composition; and
wherein said at least one sacrificial layer is formed by a first cross-linking reaction of said first composition and said at least one permanent layer is formed by a second cross-linking reaction of said second composition;
wherein said first cross-linking reaction and said second cross- linking reaction are induced by said common activator.

### Claim 59 (depends on 58)

A method according to claim 58, wherein said substrate provides said common activator for inducing said first cross-linking reaction in said first composition and said second cross-linking reaction in said second composition, wherein preferably said common activator is a chemical agent, preferably an organic compound, a metal salt or ion, an acid or a base, wherein preferably said common activator is a metal ion, preferably an alkali metal ion or an alkaline earth metal ion, or wherein said common activator is a calcium ion, preferably Ca2+.

### Claim at position 38

60-62. (canceled)

### Claim 63 (depends on 58)

A method according to claim 58, wherein said at least one sacrificial layer is degradable by a reaction that does not degrade said at least one permanent layer, wherein preferably the method further comprises the step of selectively removing, in particular degrading, said at least one sacrificial layer to obtain at least one hollow space, wherein preferably said selective removal of said at least one sacrificial layer is a biocompatible process, and wherein preferably an enzyme, preferably an alginate lyase, is used to selectively remove said at least one sacrificial layer, wherein preferably said at least one hollow space forms a network, in particular a microfluidic network, of perfusable channels.

### Claim at position 40

64-66. (canceled)

### Claim 67 (depends on 58)

A method according to claim 58, wherein said first and/or second composition further comprises living cells, preferably mammalian cells.

### Claim 68 (depends on 67)

A method according to claim 67, wherein upon the selective removal, preferably degradation, of said at least one sacrificial layer, said living cells are deposited on at least one surface of said at least one permanent layer, preferably in a nonuniform distribution and wherein preferably said at least one sacrificial layer or said at least one permanent layer is deposited by extrusion or by printing preferably by thermal or piezoelectric ink jet printing.

### Claim at position 43

69-72. (canceled)

### Claim 73 (depends on 58)

A method according to claim 58, wherein said depositing of said at least one sacrificial layer and said at least one permanent layer is effected by a plurality of dispensing units that are aligned and synchronized to one another.

### Claim 74 (depends on 57)

A structure produced by a method according to claim 57.

### Claim 75 (depends on 74)

A structure according to claim 74, wherein said network of perfusable channels further comprises inlet and outlet channels that are connectable with an inlet and an outlet of a perfusion chamber.

### Claim 76 (depends on 73)

A method for aligning and synchronizing multiple dispensing units, preferably in a method according to claim 73, wherein a multi-component test-pattern is deposited and assessed.

### Claim 77 (depends on 76)

A method according to claim 76, wherein said multi-component test-pattern comprises arrayed lines that are preferably obtained by depositing single dots with different dispensing units, wherein preferably the multi-component test-pattern is imaged, in particular microscopically, and the quality of the alignment is evaluated by image analyzing techniques, in particular by linear interpolation methods.

### Claim 78

(canceled)

### Claim 79 (depends on 53)

A method of providing an artificial tissue using a structure as claimed in claims 53 as a template, wherein preferably said artificial tissue is selected from the list comprising brain tissue, skin tissue, ocular tissue, muscular tissue, pulmonary tissue, cardiac tissue, venous tissue, artery tissue, lymphoid tissue, mammary tissue, thymus tissue, stomach tissue, liver tissue, pancreatic tissue, intestinal tissue, kidney tissue, bladder tissue, cartilage tissue, tendon tissue and bone tissue.

### Claim 80

(canceled)

### Claim 81 (depends on 79)

An artificial tissue produced by a method according to claim 79.
